Piasecki to lead Torre Lazur U.S. as Breitenbach exits

Share this article:
Torre Lazur McCann has appointed Marci Piasecki chief executive for its U.S. operations following the resignation of Beverley Breitenbach. Piasecki, who previously headed East Hanover, N.J.-based Echo Torre Lazur, reports to Richard Nordstrom, chairman and chief executive of Torre Lazur McCann Worldwide. She heads Torre Lazur McCann U.S. offices in Parsippany and East Hanover, N.J., San Diego and Chicago.
Piasecki worked for Torre Lazur McCann from 1992-2001, handling GlaxoSmithKline oncology and vaccine accounts, before joining Hyphen, where she headed client services. She re-joined Torre Lazur McCann in November, 2004.
Torre Lazur McCann said Breitenbach had resigned her post and "separately will announce future plans." Breitenbach could not be reached for this story.
Share this article:

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.